undamentalytics Newsletter
Sign in

Orthopediatrics Corp revenue

Orthopediatrics Corp's revenue was $236m in fiscal 2025, up 15.4% on the year before. Since fiscal 2015 ($31.0m) it has grown at a compound 22.5% a year. Over the last twelve months it was $264m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue31374658737198122149205236264
Growth on the year before—+20.3%+22.3%+26.2%+26.0%−2.0%+37.9%+24.7%+21.6%+37.6%+15.4%—
Gross profit2226344355557391111149173195

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Trauma and Deformity $166M 70.4% ▲ 14.6%
Spine $66M 27.9% ▲ 19.8%
Sports Medicine and Other $4M 1.7% ▼ 10.1%
Geography
Region Revenue Share YoY
United States $186M 78.9% ▲ 15.7%
Outside the US $49.9M 21.1% ▲ 14.6%

From Orthopediatrics Corp's 10-K filed March 4, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Orthopediatrics Corp $264m 16.1% 23.0%
Lemaitre Vascular Inc $262m 11.8% 14.0%
Axogen, Inc. $267m 24.3% 20.6%
Cerus Corp $254m 74.6% 89.8%
Establishment Labs Holdings Inc. $246m 38.6% 11.5%
Skinhealth Systems Inc. $290m -6.5% -9.5%

Compare with peers

Head to head: KIDS vs LMATAXGN vs KIDSCERS vs KIDSESTA vs KIDS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Orthopediatrics Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Orthopediatrics Corp.